Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase NA 14Phase 3 13Phase 1 4Phase 4 3Phase 2/3 2Phase 1/2 2

Status

Completed 5Recruiting 4Unknown 2Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 29Thoracic 21Breast 14Other hematologic neoplasm 13Genitourinary 11Lymphoid 10Gynecologic 9Head & Neck 8Dermatologic 6CNS 6Sarcoma 5Myeloid 5Plasma cell 4Tumor-Agnostic 3Other 2Endocrine 2Other solid neoplasm 1NET 1Classical hematology 1

Conditions

Stomatitis 1Oropharyngeal Neoplasms 1Oral Ulcer 1Opioid-Induced Constipation 1Mucositis 1Head and Neck Neoplasms 1Constipation 1

Interventions

tegaserod 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Terminated × Other × Clear all
NCT04648020 2023-05-31

VOICE

Monopar Therapeutics

Phase 2/3 Terminated
190 enrolled
Head & NeckOther

Head and Neck Neoplasms, Oropharyngeal Neoplasms, Stomatitis, Oral Ulcer, Mucositis

NCT00365820 2012-04-20

Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain

Novartis

Phase 2/3 Terminated
670 enrolled
Other

Opioid-Induced Constipation, Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡